Solid biosciences Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Solid biosciences Contact Number

Contact Us • Solid Biosciences

2 hours ago Solidbio.com Show details

(617) 337-4680Solid BiosciencesCorporate Headquarters. 141 Portland Street Fifth Floor Cambridge, MA 02139 United States (617) 337-4680.

Phone: (617) 337-4680
1. 141 Portland St, Cambridge, MA 02139 · (617) 337-4680DIRECTIONSWEBSITE

Category: Contact SupportShow more

Solid Biosciences Crunchbase Company Profile & Funding

7 hours ago Crunchbase.com Show details

Company Type For Profit. Contact Email [email protected] Phone Number +16173374682. Solid Biosciences is to cure Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. DMD is a progressive, irreversible and ultimately fatal

Founder: Ilan Ganot

Category: Contact NumberShow more

Solid Biosciences Securities Corporation Company Profile

4 hours ago Dnb.com Show details

Solid Biosciences Securities Corporation is located in Cambridge, MA, United States and is part of the Scientific Research and Development Services Industry. Solid Biosciences Securities Corporation has 1 total employees across all of its locations and generates $221,232 in sales (USD). (Employees and Sales figures are modelled).

Category: Contact NumberShow more

Solid Biosciences Overview, News & Competitors

8 hours ago Zoominfo.com Show details

(617) 337-4680Solid Biosciences Provides Third Quarter 2021 Business Update and Financial Results - Continued focus on advancing SGT-001 includes additional patient dosings in IGNITE DMD expected to begin in Q4 2021 - - Continued progress with SGT-003; Solid’s next-generation Duchenne gene therapy program demonstrates enhanced muscle tropism and …

Employees: 121
Phone: (617) 337-4680
Location: 141 Portland St, Fifth Floor, Cambridge, 02139, Massachusetts

Category: Contact NumberShow more

Solid BioSciences Company Profile Office Locations

4 hours ago Craft.co Show details

Solid BioSciences has 1.14k Twitter Followers. The number of followers has increased 4.9% month over month and increased 12.4% quarter over quarter

Category: Contact NumberShow more

Solid Biosciences Provides SGT001 Program Update

1 hours ago Solidbio.com Show details

617-337-4680Investor Contact: Carlo Tanzi, Ph.D. Kendall Investor Relations 617-337-4680 [email protected] Media Contact: Courtney Heath ScientPR 416-301-7966 [email protected] Source: Solid Biosciences Inc.

Category: Contact NumberShow more

EIN 900943402 Solid Biosciences Inc., Cambridge

2 hours ago Eintaxid.com Show details

The Employer Identification Number (EIN) for Solid Biosciences Inc. is 90-0943402. EIN numbers are also referred to as FEIN or FTIN. Find EIN, …

Category: Contact NumberShow more

Solid Biosciences and Forge Biologics Announce Viral

7 hours ago Solidbio.com Show details

CAMBRIDGE, Mass. & COLUMBUS, Ohio--(BUSINESS WIRE)--Oct. 4, 2021-- Solid Biosciences Inc. (Solid, Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), and Forge Biologics, a cell and gene therapy-focused contract development and manufacturing organization (CDMO), …

Category: Contact NumberShow more

Solid Biosciences Email Format solidbio.com Emails

Just Now Rocketreach.co Show details

Solid Biosciences Email Format. Solid Biosciences uses 1 email formats. The most common Solid Biosciences email format is first (ex. [email protected]) being used 100.0% of the time. Get Verified Emails for Solid Biosciences Employees. Solid Biosciences's Email Format.

Category: Contact NumberShow more

Contact us BioSchwartz

Just Now Bioschwartz.com Show details

For fastest service, please send us an email if you have a question about our products or need assistance with your order. Our phone lines are open from 9AM - …

Category: Contact SupportShow more

Ilan Ganot CoFounder & President & CEO @ Solid

4 hours ago Crunchbase.com Show details

Ilan Ganot is Co-Founder, President & Chief Executive Officer of Solid Biosciences and a member of the board of directors. Ilan Ganot started Solid in 2013 to find treatments, and potentially a cure, for Duchenne muscular dystrophy, a disease that afflicts his son Eytani. Prior to starting Solid, Ilan Ganot was an investment banker at.

Category: Contact NumberShow more

Solid Biosciences Provides Third Quarter 2021 Business

9 hours ago Stockhouse.com Show details

212-867-1768Investor Contact: David Carey FINN Partners 212-867-1768 [email protected] Caitlin Lowie Solid Biosciences 607-423-3219 [email protected] Media Contact: Erich Sandoval FINN Partners 917-497-2867 [email protected]

Category: Contact NumberShow more

Solid Biosciences Inc. (SLDB) Company Profile & Facts

5 hours ago Finance.yahoo.com Show details

See the company profile for Solid Biosciences Inc. (SLDB) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and

Category: Contact NumberShow more

SLDB Solid Biosciences Inc. • BioPharmCatalyst

5 hours ago Biopharmcatalyst.com Show details

Solid Biosciences Inc. ((Solid, NASDAQ:SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), and Forge Biologics, a cell and gene therapy-focused contract development and manufacturing organization (CDMO), announced a partnership to advance the development and manufacturing of SGT

Category: Contact NumberShow more

Solid Biosciences LinkedIn

Just Now Linkedin.com Show details

Solid Biosciences 4,370 followers on LinkedIn. #TogetherWeAreSolid Solid Biosciences (Solid) is a life science company singularly focused on solving Duchenne muscular dystrophy (Duchenne). We

Category: Contact NumberShow more

Solid Biosciences Employees, Board Members, Advisors

4 hours ago Crunchbase.com Show details

Number of Board Member and Advisor Profiles 10 Solid Biosciences has 10 board members and advisors, including Martin Freed . Martin Freed Board Member Jun 2018

Category: Contact NumberShow more

Anastasiya Kelly Executive As.. Solid Biosciences

4 hours ago Zoominfo.com Show details

View Anastasiya Kelly's business profile as Executive Assistant & Contracts Administrator at Solid Biosciences. Find contact's direct phone number, email address, work history, and more.

Category: Contact NumberShow more

Solid Biosciences to Provide Update on LongTerm Outcomes

1 hours ago Globenewswire.com Show details

607-423-3219Investor Contact: Caitlin Lowie Solid Biosciences 607-423-3219 [email protected] David Carey FINN Partners 212-867-1768 [email protected] Media Contact: Erich Sandoval FINN Partners

1. Author: Solid Biosciences Inc.

Category: Contact NumberShow more

Investor Relations Solid Biosciences Inc.

1 hours ago Investors.solidbio.com Show details

Solid Biosciences is a life science company focused solely on finding meaningful therapies for Duchenne muscular dystrophy (Duchenne). Founded by those touched by the disease, Solid is a center of excellence for Duchenne, bringing together experts in science, technology and care to drive forward a portfolio of candidates that have life-changing potential.

Category: Contact NumberShow more

Solid Biosciences Provides Third Quarter 2021 Business

7 hours ago Investors.solidbio.com Show details

212-867-1768Investor Contact: David Carey FINN Partners 212-867-1768 [email protected] Caitlin Lowie Solid Biosciences 607-423-3219 [email protected] Media Contact: Erich Sandoval FINN Partners 917-497-2867 [email protected] Source: Solid Biosciences Inc.

Category: Contact NumberShow more

Solid Biosciences to Present at Upcoming Scientific

1 hours ago Finance.yahoo.com Show details

CAMBRIDGE, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy

Category: Contact NumberShow more

Two More Patients Dosed in Solid Trial of DMD Gene Therapy

9 hours ago Musculardystrophynews.com Show details

Two more participants have been dosed in the IGNITE DMD clinical trial, bringing to eight the total number of Duchenne muscular dystrophy (DMD) patients thus far given Solid Biosciences‘ investigational gene therapy SGT-001.. The U.S. trial is testing SGT-001’s safety and efficacy in boys with DMD ages 4 to 17.

Category: Contact NumberShow more

Solid Biosciences and Forge Biologics Announce Viral

5 hours ago Investors.solidbio.com Show details

Partnership to Bolster Solid Biosciences’ Gene Therapy Pipeline, Including AAV Process Development, Scale Up and cGMP Manufacturing Services CAMBRIDGE, Mass. & COLUMBUS, Ohio--(BUSINESS WIRE)--Oct. 4, 2021-- Solid Biosciences Inc. (Solid, Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne …

Category: Contact NumberShow more

Is Solid Stock a good investment? SLDB 2.17 0.12 (5.2402%)

4 hours ago Macroaxis.com Show details

Solid Biosciences is trading at 2.17 as of the 10th of November 2021, a -5.24 percent down since the beginning of the trading day. The stock's open price was 2.29. Get the latest Solid Biosciences detailed stock quotes, stock trade data, stock price info, and performance analysis, including Solid Stock investment advice, charts, stats and more.

Category: Contact NumberShow more

Ultragenyx Pharmaceutical Funding, Financials, Valuation

4 hours ago Crunchbase.com Show details

Ultragenyx Pharmaceutical is funded by 9 investors. Takeda Ventures, Inc. and Takeda are the most recent investors. Ultragenyx Pharmaceutical has invested in Solid Biosciences on Oct 23, 2020. This investment - Post-IPO Equity - Solid Biosciences - was valued at $40M. Ultragenyx Pharmaceutical has had 1 exit, which was Solid Biosciences.

Category: Contact NumberShow more

Corporate Overview Solid Biosciences

1 hours ago Investors.solidbio.com Show details

12-40-47Mutation agnostic • Addresses the underlying genetic cause of DMD • Based on rigorous selection process Body-wide muscle expression • In animals, demonstrated expression in muscles, including the heart

Category: Contact NumberShow more

SOLID BIOSCIENCES INC. : SLDB Stock Price US83422E1055

4 hours ago Marketscreener.com Show details

Solid Biosciences Inc. is a life science company. The Company is focused on advancing transformative treatments to improve the lives of patients living with Duchenne. Its lead program, SGT-001, is a gene transfer candidate under investigation for its ability to drive functional dystrophin protein expression in patient’s muscles and

Category: Contact NumberShow more

Brianna Daybre HR Business Pa.. Solid Biosciences

2 hours ago Zoominfo.com Show details

View Brianna Daybre's business profile as HR Business Partner at Solid Biosciences. Find contact's direct phone number, email address, work history, and more.

Category: Contact NumberShow more

Letter to the Duchenne Community: IGNITE DMD Phase I/II

8 hours ago Marketscreener.com Show details

Disclaimer. Solid Biosciences Inc. published this content on 03 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 November 2021 11:24:07 UTC.

Category: Contact NumberShow more

SLDB Stock Forecast, Price & News (Solid Biosciences)

6 hours ago Marketbeat.com Show details

7 brokerages have issued 12 month price objectives for Solid Biosciences' shares. Their predictions range from $8.00 to $57.00. On average, they expect Solid Biosciences' stock price to reach $33.60 in the next twelve months. This suggests a possible upside of 266.0% from the stock's current price. View Analyst Price Targets for Solid Biosciences.

Category: Contact NumberShow more

Solid Biosciences and Forge Biologics Announce Viral

2 hours ago Businesswire.com Show details

About Solid Biosciences. Any forward-looking statements are based on management’s current expectations of future events and are subject to a number of risks and uncertainties that could

Category: Contact NumberShow more

Solid Biosciences and Forge Biologics Announce Viral

8 hours ago Finance.yahoo.com Show details

CAMBRIDGE, Mass. & COLUMBUS, Ohio, October 04, 2021--(BUSINESS WIRE)--Solid Biosciences Inc. (Solid, Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne

Category: Contact NumberShow more

Solid Biosciences, Llc, Jobs & Salary for Foreign Workers

9 hours ago Myvisajobs.com Show details

Solid Biosciences, Llc has filed 11 labor condition applications for H1B visa and 0 labor certifications for green card from fiscal year 2018 to 2020. Solid Biosciences was ranked 15822 among all visa sponsors. Please note that 1 LCA for H1B Visa and 0 LC for green card have been denied or withdrawn during the same period.

Category: Contact NumberShow more

Contact SOLiD for Multi Operator Distributed Antenna System

9 hours ago Solid.com Show details

(888) 409-9997HQ / Shipping & Receiving 800 Klein Road Suite 200 Plano, TX 75074 (888) 409-9997 [email protected]solid.com

Category: Contact SupportShow more

How to buy Solid Biosciences stock 16 Nov price $2.1

3 hours ago Finder.com Show details

Since the stock market crash in March caused by coronavirus, Solid Biosciences's stock price has had significant negative movement. Its last market close was $2.1, which is 36.17% down on its pre-crash value of $3.29 and 7.14% up on the lowest point reached during the March crash when the stocks fell as low as $1.96.

Category: Contact NumberShow more

Solid Biosciences Inc. (SLDB) Company Profile & Overview

6 hours ago Stockanalysis.com Show details

Solid Biosciences Inc., a life science company, engages in developing therapies for duchenne muscular dystrophy (DMD) in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles.

Category: Contact NumberShow more

Solid Biosciences Announces New Preclinical Data at the

4 hours ago Globenewswire.com Show details

About Solid Biosciences Any forward-looking statements are based on management’s current expectations of future events and are subject to a number of risks and uncertainties that could cause

Category: Contact NumberShow more

Solid Biosciences Highlights Expertise in AAV Gene Therapy

8 hours ago Finance.yahoo.com Show details

-Data from studies of novel AAV vectors and AAV immunology and an encore of 12-month safety, efficacy and patient-reported outcomes measurements from the ongoing IGNITE DMD trial of SGT001 to be

Category: Contact NumberShow more

Solid Biosciences Inc (SLDB) is down 5.04% in a Week

7 hours ago Investorsobserver.com Show details

Solid Biosciences Inc is near the top in its industry group according to InvestorsObserver.SLDB gets an overall rating of 46. That means it scores higher than 46 percent of stocks. Solid Biosciences Inc gets a 87 rank in the Drug Manufacturers - Specialty & Generic industry. Drug Manufacturers - Specialty & Generic is number 140 out of 148 industries.

Category: Contact NumberShow more

Ultragenyx and Solid Biosciences Announce Strategic

2 hours ago Ir.ultragenyx.com Show details

Solid Biosciences is a life sciences company focused on advancing transformative treatments to improve the lives of patients living with Duchenne. Disease-focused and founded by a family directly impacted by Duchenne, our mandate is simple yet comprehensive – work to address the disease at its core by correcting the underlying mutation …

Category: Contact NumberShow more

Solid Biosciences Jobs, Employment Indeed.com

2 hours ago Indeed.com Show details

Solid Biosciences, Inc. 3.0. Cambridge, MA 02139 (Area IV area) Solid Biosciences is looking for a Senior Clinical Scientist who will support Solid’s clinical development programs by contributing to the design, data…. 30+ days ago ·. More View all Solid Biosciences, Inc. jobs in Cambridge, MA - Cambridge jobs.

Category: Contact NumberShow more

Anixa Biosciences Announces Patient Dosing of its

8 hours ago Finance.yahoo.com Show details

Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa") a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that, in conjunction with its

Category: Contact NumberShow more

Solid Biosciences and Forge Biologics Announce Viral

8 hours ago Biospace.com Show details

CAMBRIDGE, Mass. & COLUMBUS, Ohio--(BUSINESS WIRE)-- Solid Biosciences (Solid, Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), and Forge Biologics, a cell and gene therapy-focused contract development and manufacturing organization (CDMO), announced a …

Category: Contact NumberShow more

Solid Biosciences : Development activities continue for

6 hours ago Marketscreener.com Show details

212-867-1768Investor Contact: David Carey FINN Partners 212-867-1768 [email protected] Caitlin Lowie Solid Biosciences 607-423-3219 [email protected] Media Contact: Erich Sandoval FINN Partners 917-497-2867 [email protected]

Category: Contact NumberShow more

Solid Biosciences Tech Stack, Apps, Patents & Trademarks

8 hours ago Crunchbase.com Show details

Solid Biosciences uses 24 technology products and services including HTML5 , Google Analytics , and jQuery, according to G2 Stack. Solid Biosciences is actively using 32 technologies for its website, according to BuiltWith. These include Viewport Meta , IPhone / Mobile Compatible , and SPF.

Category: Tech SupportShow more

Solid Biosciences to Provide Update on LongTerm Outcomes

9 hours ago Marketscreener.com Show details

607-423-3219Investor Contact: Caitlin Lowie Solid Biosciences 607-423-3219 [email protected] David Carey FINN Partners 212-867-1768 [email protected] Media Contact: Erich Sandoval FINN Partners 917-497-2867 [email protected]

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What does solid Biosciences do?

- Chief Operating Officer to discuss company’s advanced AAV gene therapy manufacturing capabilities and best practices for orphan drug development - CAMBRIDGE, Mass. , Aug. 24, 2021 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful

Who owns solid Biosciences stock?

Solid Biosciences' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Rhumbline Advisers (0.05%). Company insiders that own Solid Biosciences stock include Boxer Capital, Llc, Ilan Ganot, Joel Solomon Zev Schneider, Jorge Armando Quiroz,...

How did solidsolid Biosciences' short interest look in July?

Solid Biosciences saw a increase in short interest in the month of July. As of July 30th, there was short interest totaling 6,850,000 shares, an increase of 14.7% from the July 15th total of 5,970,000 shares. Based on an average daily volume of 905,600 shares, the days-to-cover ratio is currently 7.6 days.

How has coronavirus affected solidsolid Biosciences' stock?

Solid Biosciences' stock was trading at $3.14 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, SLDB stock has decreased by 15.0% and is now trading at $2.67. View which stocks have been most impacted by COVID-19.

Popular Brands

Sharp
Shell
Sap
Sgs
Sabb
Sea